Google News Alert for: weight loss
| Qnexa Meets Primary Endpoint by Demonstrating Superior Weight Loss ... MarketWatch - USA The EQUATE study met the primary endpoint by demonstrating superior weight loss with both the full-dose and mid-dose of Qnexa, as compared to the individual ... See all stories on this topic |
| Vivus says obesity drug leads to 9 pct weight loss Reuters - USA Vivus said the 28-week, 756-patient study met its main goal of superior weight loss with two different doses of Qnexa, compared with the drug's individual ... See all stories on this topic |
This as-it-happens Google Alert is brought to you by Google.
Create another alert.
Manage your alerts.
No comments:
Post a Comment